Best Stem Cell Treatment for Diabetes in Beijing, China

Publish date: Medically reviewed by: Dr. Xiaodi Han on Aug 20, 2026 Author: Pinki Sharma

Medical Center Reviews

$15,710 Price starting from

Chinese couple in distress after seeing diabetes in glucometer

Diabetes management leaves very little room for guesswork, especially when travel is involved. This package has a stated starting price of $15,710 USD for a proposed cell-based intervention for diabetes at Beijing Puhua International Hospital. The supplied title is retained here, but no treatment should be called “best” for an individual without a complete medical assessment. It is not a substitute for insulin, glucose monitoring, prescribed medication, nutrition planning, or urgent diabetes care.

Diabetes type, blood-glucose patterns, history of severe hypoglycemia, insulin use, kidney function, eye disease, nerve symptoms, infection risk, and heart health all affect travel and treatment decisions. Eligibility, product, route, stay, inclusions, and final cost need written confirmation after review.

Key Insights for Diabetes Stem Cell Therapy in Beijing

  • Starting estimate: $15,710 USD is a planning figure, not a final medical invoice.
  • Standard care continues: never stop insulin, tablets, monitoring, or other diabetes treatment without direct instructions from the diabetes team.
  • Cell therapy is specific: an FDA-approved pancreatic islet cellular therapy exists for a narrow group of adults with type 1 diabetes and repeated severe hypoglycemia; that does not establish the safety or effectiveness of another cell product or protocol.
  • Product questions matter: ask for the cell source, processing laboratory, identity, dose, route, sterility, donor screening, monitoring, and adverse-event plan.
  • Travel planning is clinical: carry supplies in hand luggage, protect insulin from temperature extremes, and have a plan for high or low blood glucose.
  • Independent review: ask an endocrinologist or diabetes clinician to review the proposal before booking.

How Much Does Diabetes Stem Cell Therapy Cost in Beijing?

The supplied starting package cost is $15,710 USD. It is not a directly comparable routine-care price in the United States, Canada, United Kingdom, or Australia because diabetes treatment varies by type and established care includes medication, insulin, glucose monitoring, education, and management of complications. Cost does not demonstrate safety, evidence, or suitability.

Country Indicative cost Planning context
Beijing, China From $15,710 USD Supplied starting package price; final quote follows assessment.
United States No like-for-like routine-care price FDA-approved cellular therapy has narrow eligibility and is not a general diabetes treatment.
Canada / United Kingdom / Australia No equivalent standard-care price Compare the protocol, safety, complication planning, and ongoing diabetes care.

Known $15,710 Starting Price Breakdown

No itemized billing sheet was supplied for this package. The table states only what is known and avoids creating separate provider charges.

Procedure item Estimate Description
Diabetes cell-based package From $15,710 Starting amount; individual services were not itemized.
Assessment, tests, product, administration, observation Confirm in writing Ask exactly what is included and what can add cost.
Flights, hotel, meals, glucose supplies, insurance, home care Confirm separately Do not assume travel or diabetes supplies are included.
Total starting estimate $15,710 Subject to medical review and written confirmation.

What to Confirm Before Traveling for Diabetes Care

  • Whether records review, endocrinology assessment, laboratory testing, the named product, procedure, observation, discharge records, and remote follow-up are included.
  • Whether flights, accommodation, meals, translators, additional tests, emergency treatment, complications, glucose supplies, and home follow-up are excluded.
  • Who will manage insulin, pumps, continuous glucose monitors, hypoglycemia, hyperglycemia, sick-day rules, food timing, and changes in time zone.
  • What evidence applies to the exact diabetes type and complication profile, not diabetes in general.

Who May Be Assessed for a Diabetes Cell-Therapy Package?

Diabetes is not one condition, and treatment needs vary. A patient may be considered for evaluation only after a detailed review by appropriate clinicians. High-risk people may need diabetes stabilization or other care before international travel is considered.

  • Confirmed type 1, type 2, or another documented form of diabetes.
  • Current medication, insulin, glucose-monitoring, and complication-management plan.
  • Recent A1C, glucose records, kidney function, blood pressure, and relevant specialist assessments.
  • Medical stability for travel and the proposed clinical setting, determined by clinicians.
  • Realistic expectations: no promise of insulin independence, diabetes cure, or prevention of complications.
  • A plan to continue established diabetes care after returning home.

Medical Records Needed Before Traveling to Beijing

  • Diabetes type, diagnosis history, recent endocrinology notes, and treatment plan.
  • A1C, glucose logs or continuous-monitor data, hypoglycemia episodes, and hospitalizations for high or low glucose.
  • Insulin, pump, oral medicine, supplement, and allergy lists.
  • Kidney, eye, nerve, cardiovascular, foot, infection, and wound-care records where relevant.
  • Recent laboratory results, imaging, and specialist reports.
  • Travel letter, prescriptions, emergency contacts, and a diabetes action plan.

How a Proposed Diabetes Cell-Based Intervention Should Be Explained

The clinician should explain the exact product and what it is intended to do, without treating all cell therapies as the same. Ask how the proposed treatment differs from established diabetes care, why it is suitable for this specific patient, and what research supports the actual product and route.

  1. Independent diabetes review: discuss the plan with the regular endocrinologist or diabetes clinician.
  2. Records assessment: review glucose control, insulin needs, complications, medicines, and travel readiness.
  3. Protocol disclosure: request cell source, laboratory, identity, dose, route, sterility, monitoring, risks, and full costs.
  4. Consent: discuss uncertainty, alternatives, foreseeable harms, and what happens if there is no benefit.
  5. Procedure and observation: receive only the documented intervention and continue prescribed diabetes monitoring.
  6. Discharge: receive records, emergency contacts, and a return-home diabetes plan.

Beijing Treatment Timeline and Length of Stay

Before travel: send records, obtain independent review, clarify all product and price questions, and organize medication and supply storage.

Arrival: attend an in-person assessment; additional tests may be required and the plan may change.

Treatment and monitoring: follow the documented clinical protocol while continuing essential glucose monitoring and medication management.

Pre-travel review: the treating clinician determines whether return travel is appropriate.

Return home: share discharge records with the regular diabetes team and continue care.

Length of stay depends on the actual protocol, glucose stability, complications, and travel plan. Keep flights flexible until the treating clinician provides clearance.

Recovery, Aftercare, and Possible Complications

Follow instructions on glucose testing, meals, insulin or other medicines, hydration, and symptom reporting. Travel can alter food, activity, sleep, temperature exposure, and medication timing, so it may affect blood glucose. Carry fast-acting carbohydrate, a meter or continuous-monitor supplies, medication, and an emergency plan.

This list is not exhaustive. The clinician should discuss risks of the exact product, processing, route, diabetes type, immune status, and travel before consent.

  • Injection or procedure-site pain, bleeding, allergic, inflammatory, or immune reactions.
  • Infection or contamination risk, including potentially serious infection.
  • Hypoglycemia, hyperglycemia, dehydration, or ketoacidosis risk if routine diabetes care is disrupted.
  • Route-specific or sedation-related complications if relevant.
  • Unexpected biological effects and unknown long-term risks of unproven interventions.
  • No benefit, financial loss, or delayed treatment of diabetes complications.

Expected Results and Realistic Goals

No general cell-treatment package should promise diabetes reversal, insulin independence, normalized A1C, or prevention of future complications. Results depend on diabetes type, the actual product, patient selection, monitoring, and evidence quality. The safest expectation is a transparent discussion that protects standard diabetes care and records both benefits and harms honestly.

About Beijing Puhua International Hospital

Beijing Puhua International Hospital is listed at No.12 Tiantan Nanli, Dongcheng District, Beijing, China. Its provider profile lists 62 beds, two operating theaters, and a 24/7 intensive care unit, and identifies stem cell therapy, chronic diseases, and neurology as specialties. These profile details should be independently confirmed for the exact diabetes protocol, including the responsible clinician, facility authorization, laboratory documentation, and emergency arrangements.

Frequently Asked Questions About Diabetes Stem Cell Therapy in Beijing

1. Does “best” mean this is the right treatment for me?

No. The right treatment depends on diabetes type, risks, goals, evidence, and a full medical assessment.

2. What does the $15,710 starting price include?

Only a starting figure is supplied. Request a signed, itemized quote.

3. Can I stop insulin or diabetes medicines?

No. Do not change prescribed diabetes treatment without direct instructions from your diabetes team.

4. Is every cell therapy for diabetes the same?

No. Ask about the exact cell source, product, route, evidence, and eligibility.

5. What should I pack for international travel?

Carry medicines, glucose-monitoring supplies, snacks, emergency treatment, prescriptions, and a clinician letter in hand luggage.

6. Can diabetes supplies be damaged in travel?

Yes. Heat, freezing, and checked baggage can affect some medicines and equipment; follow storage instructions.

7. What if my glucose is high or low after treatment?

Use the written diabetes action plan and seek urgent medical care when appropriate.

8. Does a research registry prove the treatment works?

No. Registration does not establish approval, safety, or effectiveness for an individual.

9. Should a caregiver travel with me?

For people at risk of severe hypoglycemia or with complications, a caregiver may be important; discuss this with the diabetes team.

10. Should I seek independent medical advice?

Yes. An endocrinologist or diabetes clinician can review risks, alternatives, travel, and follow-up.

Request a Written Diabetes Treatment Quote

Ask for the full protocol, product details, itemized costs, glucose-management plan, emergency arrangements, and follow-up plan before deciding.

Request Free Quote

Medical Disclaimer

This content is for general informational and educational purposes only and does not diagnose, recommend a provider, or replace care from qualified diabetes clinicians. Eligibility, risks, treatment selection, travel clearance, and final pricing require individual medical assessment and written provider confirmation.

Medical and Patient Safety References

  1. NIDDK – Managing Diabetes
  2. FDA – First Cellular Therapy for a Defined Type 1 Diabetes Population
  3. ISSCR – Guide to Stem Cell Treatments
  4. CDC – Tips for Traveling With Diabetes
  5. CDC Yellow Book – Medical Tourism

Related Experiences:

Stem Cell Therapy for Diabetes in Tokyo, Japan
Regenerative Medicine for Diabetes in United States
Stem Cell Therapy in India for Diabetes Type 2
Stem Cell Therapy for Diabetes in Japan
Stem Cell Therapy in India for Diabetes Type 1
Stem Cell Therapy for Diabetes in Germany: Compare Options With Clear Eyes

Location

Best Stem Cell Treatment for Diabetes in Beijing, China thumbnail

About Package

  • Translations: EN ID RU ZH VI AR
  • Associated Center: Beijing Tiantan Puhua International Hospital, Ltd in China
  • Treatment: Stem Cell Therapy,Stem Cell Treatment for Diabetes
  • Location:
    #12 Tiantan Nanli, Dongcheng District, China
  • Focus Area: Diabetes Treatment | Stem Cell Therapy for Diabetes | Beijing | China | Stem Cell Diabetes Package | Diabetes Stem Cell Therapy Cost
  • Overview Diabetic condition is a common life-long condition, and the number of children diagnosed with type 1 diabetes is on the rise. In Beijing Puhua International Hospital, stem cells are used to help control blood sugar better and reduce insulin intake so that the symptoms can be controlled rather than cured. Find out more about Beijing's best stem cell treatment package for diabetes by clicking here.

Trusted Medical Tourism Platform Since 2007

60+
Countries
2k+
Clinics
19.5k+
Reviews
2.5k+
Qualified Doctors
1.1M+
Patients Served Since 2007